tetano
Editor, Senior Moderator
Hum Antibodies
. 2022 Dec 26.
doi: 10.3233/HAB-220011. Online ahead of print.
The impact of HIV on the risk of COVID-19 death among hospitalized patients
Mehdi Azizmohammad Looha[SUP] 1 [/SUP], Nazanin Taraghikhah[SUP] 2 [/SUP], Maedeh Amini[SUP] 1 [/SUP], Pegah Salimi Pormehr[SUP] 3 [/SUP], Negin Talaei[SUP] 4 [/SUP], Mahmood Khodadoost[SUP] 5 [/SUP], Saeid Gholamzadeh[SUP] 6 [/SUP], Reza Vafaee[SUP] 7 [/SUP], Gohar Mohammadi[SUP] 6 [/SUP]
Affiliations
Abstract
Background: Little is known about the association between Human Immunodeficiency Virus (HIV) infection and risk of death among hospitalized COVID-19 patients. We aimed to investigate this association using a multicenter study.
Material and methods: This multicenter study was conducted using the registry database of Coronavirus Control Operations Headquarter from March 21, 2021 to January 18, 2020 in the province of Tehran, Iran. The interest outcome was COVID-19 death among hospitalized patients living with and without HIV. The Cox regression models with robust standard error were used to estimate the association between HIV infection and risk of COVID-19 death. The subgroup and interaction analysis were also performed in this study.
Results: 326052 patients with COVID-19 were included in the study, of whom 127 (0.04%) were living with HIV. COVID-19 patients with HIV were more likely to be female, older, and to have symptoms such as fever, muscular pain, dyspnea and cough. The death proportion due to COVID-19 was 18 (14.17%) and 21595 (6.63%) among HIV and non-HIV patients, respectively. Patients living with HIV had lower mean survival time compared to those without HIV (26.49 vs. 15.31 days, P-value = 0.047). Crude risk of COVID-19 death was higher among HIV patients than in non-HIV group (hazard ratio
: 1.60, 1.08-2.37). Compared to those without HIV, higher risk of COVID-19 death was observed among patients with HIV after adjusting for sex (1.60, 1.08-2.36), comorbidities (1.49, 1.01-2.19), cancer (1.59, 1.08-2.33), and PO2 (1.68, 1.12-2.50). However, the risk of COVID-19 death was similar in patients with and without HIV after adjusting for age (1.46, 0.98-2.16) and ward (1.30, 0.89-1.89).
Conclusion: We found no strong evidence of association between HIV infection and higher risk of COVID-19 death among hospitalized patients. To determine the true impact of HIV on the risk of COVID-19 death, factors such as age, comorbidities, hospital ward, viral load, CD4 count, and antiretroviral treatment should be considered.
Keywords: COVID-19; Cox Model; HIV; SARS-CoV-2; mortality.
. 2022 Dec 26.
doi: 10.3233/HAB-220011. Online ahead of print.
The impact of HIV on the risk of COVID-19 death among hospitalized patients
Mehdi Azizmohammad Looha[SUP] 1 [/SUP], Nazanin Taraghikhah[SUP] 2 [/SUP], Maedeh Amini[SUP] 1 [/SUP], Pegah Salimi Pormehr[SUP] 3 [/SUP], Negin Talaei[SUP] 4 [/SUP], Mahmood Khodadoost[SUP] 5 [/SUP], Saeid Gholamzadeh[SUP] 6 [/SUP], Reza Vafaee[SUP] 7 [/SUP], Gohar Mohammadi[SUP] 6 [/SUP]
Affiliations
- PMID: 36617778
- DOI: 10.3233/HAB-220011
Abstract
Background: Little is known about the association between Human Immunodeficiency Virus (HIV) infection and risk of death among hospitalized COVID-19 patients. We aimed to investigate this association using a multicenter study.
Material and methods: This multicenter study was conducted using the registry database of Coronavirus Control Operations Headquarter from March 21, 2021 to January 18, 2020 in the province of Tehran, Iran. The interest outcome was COVID-19 death among hospitalized patients living with and without HIV. The Cox regression models with robust standard error were used to estimate the association between HIV infection and risk of COVID-19 death. The subgroup and interaction analysis were also performed in this study.
Results: 326052 patients with COVID-19 were included in the study, of whom 127 (0.04%) were living with HIV. COVID-19 patients with HIV were more likely to be female, older, and to have symptoms such as fever, muscular pain, dyspnea and cough. The death proportion due to COVID-19 was 18 (14.17%) and 21595 (6.63%) among HIV and non-HIV patients, respectively. Patients living with HIV had lower mean survival time compared to those without HIV (26.49 vs. 15.31 days, P-value = 0.047). Crude risk of COVID-19 death was higher among HIV patients than in non-HIV group (hazard ratio
: 1.60, 1.08-2.37). Compared to those without HIV, higher risk of COVID-19 death was observed among patients with HIV after adjusting for sex (1.60, 1.08-2.36), comorbidities (1.49, 1.01-2.19), cancer (1.59, 1.08-2.33), and PO2 (1.68, 1.12-2.50). However, the risk of COVID-19 death was similar in patients with and without HIV after adjusting for age (1.46, 0.98-2.16) and ward (1.30, 0.89-1.89).
Conclusion: We found no strong evidence of association between HIV infection and higher risk of COVID-19 death among hospitalized patients. To determine the true impact of HIV on the risk of COVID-19 death, factors such as age, comorbidities, hospital ward, viral load, CD4 count, and antiretroviral treatment should be considered.
Keywords: COVID-19; Cox Model; HIV; SARS-CoV-2; mortality.